To compare breast cancer prognosis in BRCA1 and BRCA2 mutation carriers with that in patients with sporadic disease.,An ...
...BRCA1, BRCA2, and FANCA. Finally, we characterized TH-302 activity in the three-dimensional tumor spheroid and multicell...
...BRCA1 protein was identified in 46 of 131 samples (35.1%). The expression of BRCA1 was not associated with age gender, p...
...BRCA1/2 or Lynch syndrome mutation were randomised into two groups. The control group was given the DNA test result in a...
...BRCA1 hypermethylation in sporadic breast cancer to identify a specific molecular and clinico-pathological phenotype. Ho...
...BRCA1 before and after NACT were evaluated.,A pCR was obtained in 10 of 32 cases (31%). Cancer-related (P = 0.013) and d...
...BRCA1/2 testing and their spouses/partners, this study sought to examine decision support needs and motivations for fami...
...BRCA1 and RAD51--exert tumor suppressor functions, with their loss being associated with cancer susceptibility. Moreover...
...BRCA1 and BRCA2. Defects of filamin-A impair the repair of DNA double strand breaks (DSBs), resulting in sensitization o...
...BRCA1), one of the target genes of miR-638. In summary, we suggest that miR-638 is involved in the BaP-induced carcinoge...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
